ANNUAL REPORT

Company

Sunshine Biopharma Inc.

Filed

April 12, 2019

Period of Report

December 31, 2018

Accession Number

0001654954-19-004354

A 10-K is a company's comprehensive annual report, required by the SEC. It includes audited financial statements, a description of the business, risk factors, and management's discussion of results. Learn more about 10-K filings →